Sender Company & Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $431K | Buy |
+5,198
| New | +$431K | 0.12% | 94 |
|
|
2024
Q2 | – | Sell |
-18,108
| Closed | -$1.72M | – | 53 |
|
|
2024
Q1 | $1.72M | Buy |
+18,108
| New | +$1.72M | 2.95% | 6 |
|
|
2022
Q2 | – | Sell |
-9,245
| Closed | -$831K | – | 55 |
|
|
2022
Q1 | $831K | Sell |
9,245
-72,196
| -89% | -$6.49M | 0.89% | 18 |
|
|
2021
Q4 | $9.12M | Buy |
+81,441
| New | +$9.12M | 4.67% | 1 |
|